Physician
Kurtz, Seth
Kurtz, Seth was paid $1.57M by Medicaid between Jan 2018 and Nov 2024, across 40 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.
33Billing provider infoKURTZ, SETH
MONSEY, NY 10952
MONSEY, NY 10952
33aNPI1023113453assigned 09/13/2006
33bProvider typePediatrics Physician
28Total paid$1.57M
24GClaims66,975
24DCodes billed40
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#210 of 1,983
Median peer was paid$17K
This provider vs. median93×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,531 | $419K | |
| 2019 | 6,503 | $70K | |
| 2020 | 6,123 | $93K | |
| 2021 | 19,030 | $559K | |
| 2022 | 11,359 | $221K | |
| 2023 | 5,433 | $163K | |
| 2024incomplete | 996 | $46K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 12,968 | 10,756 | $447K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 19% | 5,717 | 3,102 | $300K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 14% | 3,518 | 3,433 | $221K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 6.4% | 5,715 | 3,101 | $100K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.5% | 1,046 | 960 | $71K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.3% | 2,893 | 2,188 | $67K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 4.1% | 4,908 | 2,489 | $64K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.5% | 800 | 473 | $40K |
| 99308 | Subsequent nursing facility care, per day, straightforward | 2.5% | 2,040 | 938 | $39K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2.5% | 1,088 | 1,038 | $39K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.7% | 778 | 687 | $27K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 5,029 | 4,700 | $26K |
28 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.6% | 697 | $25K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.0% | 1,829 | $16K |
| 87070 | <1% | 3,431 | $15K | |
| 99305 | <1% | 454 | $14K | |
| 87184 | <1% | 3,193 | $9K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 113 | $7K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 586 | $6K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 205 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 360 | $5K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 58 | $4K |
| 36410 | <1% | 543 | $4K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 12 | $4K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 156 | $3K |
| 93000 | <1% | 128 | $2K | |
| 81000 | <1% | 468 | $1K | |
| 99000 | <1% | 329 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 107 | $1K |
| 94760 | <1% | 5,993 | $928.66 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 48 | $637.92 |
| 90686 | <1% | 167 | $573.15 | |
| 99304 | <1% | 16 | $501.86 | |
| 99050 | <1% | 116 | $435.26 | |
| 2010F | <1% | 68 | $265.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,040 | $249.36 |
| 85018 | <1% | 85 | $190.68 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 184 | $103.03 |
| 99051 | <1% | 44 | $70.49 | |
| 99080 | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.